AD-VANTAGE Trademark

Trademark Overview


On Wednesday, December 21, 2022, a trademark application was filed for AD-VANTAGE with the United States Patent and Trademark Office. The USPTO has given the AD-VANTAGE trademark a serial number of 79363852. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 14, 2024. This trademark is owned by ADvantage Therapeutics GmbH. The AD-VANTAGE trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Technical training relating to medical and care services related to Alzheimer' s disease

Pharmaceutical products for the treatment and/or prevention of Alzheimer' s disease intended exclusively for use by medical professionals in clinics, laboratories, medical practices and surgeries

Laboratory services, namely, analysis and tests and patient monitoring with regard to certain immune cells that are essential for the course of the disease/successful therapy, in connection with Alzheimer's disease, exclusively aimed at medical specialists in clinics, medical practices and surgeries
ad-vantage

General Information


Serial Number79363852
Word MarkAD-VANTAGE
Filing DateWednesday, December 21, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTechnical training relating to medical and care services related to Alzheimer' s disease
Goods and ServicesPharmaceutical products for the treatment and/or prevention of Alzheimer' s disease intended exclusively for use by medical professionals in clinics, laboratories, medical practices and surgeries
Goods and ServicesLaboratory services, namely, analysis and tests and patient monitoring with regard to certain immune cells that are essential for the course of the disease/successful therapy, in connection with Alzheimer's disease, exclusively aimed at medical specialists in clinics, medical practices and surgeries

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADvantage Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAT

Trademark Events


Event DateEvent Description
Friday, September 22, 2023ASSIGNED TO EXAMINER
Wednesday, October 18, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 24, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 3, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, October 3, 2023NON-FINAL ACTION WRITTEN
Wednesday, October 4, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 18, 2023REFUSAL PROCESSED BY MPU
Monday, November 13, 2023REFUSAL PROCESSED BY IB
Sunday, August 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 14, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 14, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 22, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, July 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB